Showing results (721-730 of 779) with videos related to
Sort By:
Pageof 78
Haematologica|January 1, 1996
EBVD and alternating MOPP/EBVD with or without localized field radiotherapy in advanced or unfavorably presenting Hodgkin's diseaseE M Pogliani, G L Deliliers, L Baldini, et al.Giornale Italiano Di Cardiologia (2006)|February 27, 2020
[ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs]Maurizio Giuseppe Abrignani, Angelo Zullo, Domenico Gabrielli, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 8, 2020
A tetraprenylated benzophenone 7-epiclusianone induces cell cycle arrest at G1/S transition by modulating critical regulators of cell cycle in breast cancer cell linesSimone da Silva Lamartine-Hanemann, Guilherme Álvaro Ferreira-Silva, Renato de Oliveira Horvath, et al.Bone Marrow Transplantation|January 25, 2024
Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP)Federica Galaverna, Francesco Baccelli, Daniele Zama, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2021
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational StudyMarco Franzetti, Andrea Forastieri, Noemi Borsa, et al.Leukemia|August 21, 2019
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myelomaElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.Blood Advances|September 11, 2020
Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell deathDebora Soncini, Paola Minetto, Claudia Martinuzzi, et al.The Journal of Biological Chemistry|October 22, 2014
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityDebora Soncini, Irene Caffa, Gabriele Zoppoli, et al.Plos One|October 4, 2019
Sialochemical analysis in polytraumatized patients in intensive care unitsMaria Heloisa Madruga Chaves, Amanda Rebeca da Silveira Wolf, Kelly Aline Lima Nascimento, et al.Molecular Cancer Therapeutics|December 20, 2007
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancerPatrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini, et al.Pageof 78